What is the highest a Baxter stock has ever been?
Historical daily share price chart and data for Baxter since 1981 adjusted for splits. The latest closing stock price for Baxter as of January 14, 2022 is 85.74. The all-time high Baxter stock closing price was 94.14 on April 20, 2020. The Baxter 52-week high stock price is 88.91, which is 3.7% above the current share price.
What is the latest closing stock price for Baxter?
The latest closing stock price for Baxter as of January 14, 2022 is 85.74. The all-time high Baxter stock closing price was 94.14 on April 20, 2020.
Is BaseB Baxter International Inc (Bax) a good stock to buy?
Baxter International Inc (Symbol: BAX) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.
Who is the owner of B Baxter India?
Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
See more
What is Baxter's strategic investment?
Where is Baxter manufactured?
Baxter's (BAX) strategic investment to help expand the manufacturing footprint of BPS and ensure improvement in products.
What is Baxter 2021?
DEERFIELD, Ill., November 11, 2021--Baxter announced a $100M investment in its manufacturing facility in Halle/Westfalen, Germany that will add new capacity and capabilities.
How to analyze Baxter stock price?
DEERFIELD, Ill., November 08, 2021--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today new data showing kidney patients may experience a survival rate nearly two-times higher and a prolonged time to an adverse event (AE) and hospitalization when the Sharesource remote patient management digital health platform is used to help manage home automated peritoneal dialysis (APD).1
How to determine Baxter International value?
There are several ways to analyze Baxter Stock price data. The simplest method is using a basic Baxter candlestick price chart , which shows Baxter International price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
What is technical analysis in Baxter?
Investors typically determine Baxter International value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baxter International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Where is Baxter International located?
A focus of Baxter International technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Baxter International trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...
Is Baxter stock going to rise in 2021?
Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois. Baxter International operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 50000 people.
BD (BDX) Beats on Q1 Earnings and Revenues, Raises FY22 View
Net Income Common Stock is likely to rise to about 1.4 B in 2021. Baxter International Price to Book Value is fairly stable at the moment as compared to the past year. Baxter International reported Price to Book Value of 4.72 in 2020. Price to Sales Ratio is likely to rise to 3.57 in 2021, whereas Price to Earnings Ratio are likely to drop 33.71 in 2021.
Abiomed (ABMD) Beats on Q3 Earnings, Narrows FY22 Guidance
The majority of BD's (BDX) core units witness strong revenue growth in the fiscal first quarter.
McKesson (MCK) Earnings and Revenues Beat Estimates in Q3
Abiomed's (ABMD) strength in Impella product revenues drives its Q3 top line.